Stocks and Investing Stocks and Investing
Tue, June 13, 2023
Mon, June 12, 2023
Fri, June 9, 2023
Thu, June 8, 2023

Andrew Fein Reiterated (STOK) at Strong Buy and Held Target at $35 on, Jun 8th, 2023


Published on 2024-10-28 04:16:31 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Stoke Therapeutics, Inc." (STOK) at Strong Buy and Held Target at $35 on, Jun 8th, 2023.

Andrew has made no other calls on STOK in the last 4 months.



There are 6 other peers that have a rating on STOK. Out of the 6 peers that are also analyzing STOK, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Greg Harrison of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $12 on, Monday, May 1st, 2023


These are the ratings of the 5 analyists that currently disagree with Andrew


  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $25 on, Tuesday, May 23rd, 2023
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $20 on, Friday, May 5th, 2023
  • Judah Frommer of "Credit Suisse" Reiterated at Buy and Held Target at $28 on, Friday, May 5th, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $24 on, Wednesday, April 26th, 2023
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $25 on, Tuesday, March 7th, 2023